More particularly the present invention relates to novel heterocyclic compounds, which are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28.

• 更具体而言，本发明涉及新的杂环化合物，其是能够抑制CD80与CD28间相互作用的CD80拮抗剂。